Total adiponectin in indigenous Melanesians on Kitava
(2024) In American Journal of Human Biology 36(10).- Abstract
Objectives: Experimental and small human studies have indicated that high total adiponectin levels have beneficial cardiometabolic effects. In contrast, however, high total adiponectin levels are also associated with higher all-cause and cardiovascular mortality in thoroughly adjusted epidemiological studies. To gain further insight into these seemingly contradictory results, we report results on total adiponectin from the indigenous Melanesian population of Kitava, Trobriand Islands, Papua New Guinea, where an apparent absence of cardiometabolic disease has been previously reported. Methods: Fasting levels of serum total adiponectin were measured cross-sectionally in ≥40-year-old Kitavans (n = 102) and Swedish controls matched for age... (More)
Objectives: Experimental and small human studies have indicated that high total adiponectin levels have beneficial cardiometabolic effects. In contrast, however, high total adiponectin levels are also associated with higher all-cause and cardiovascular mortality in thoroughly adjusted epidemiological studies. To gain further insight into these seemingly contradictory results, we report results on total adiponectin from the indigenous Melanesian population of Kitava, Trobriand Islands, Papua New Guinea, where an apparent absence of cardiometabolic disease has been previously reported. Methods: Fasting levels of serum total adiponectin were measured cross-sectionally in ≥40-year-old Kitavans (n = 102) and Swedish controls matched for age and sex (n = 108). Multivariable linear regression was used for the analysis of associations with total adiponectin when controlled for group, sex, smoking, hypertension and/or type 2 diabetes, age, and body mass index. Results: Total adiponectin was lower for Kitavans compared to Swedish controls (Median [Mdn] 4.6 μg/mL, range 1.0–206 μg/mL and Mdn 9.7 μg/mL, range 3.1–104 μg/mL, respectively, r =.64, p <.001). Lower total adiponectin was associated with Kitavan group, male sex (only in Swedish controls), smoking (only in Kitavans and Swedish controls combined), younger age (not in Swedish controls), higher BMI, lower total, low-density lipoprotein, high-density lipoprotein (HDL) (only in Kitavans and Swedish controls combined), and non-HDL cholesterol, and higher anti-PC IgG (only in Kitavans and Swedish controls combined). Conclusion: Total adiponectin in Kitavans was significantly lower than in Swedish controls.
(Less)
- author
- Carrera-Bastos, Pedro
LU
; Fontes-Villalba, Maelán
LU
; Ahrén, Bo LU ; Lindblad, Ulf LU ; Råstam, Lennart LU ; Frostegård, Johan ; Åkerfeldt, Torbjörn ; Granfeldt, Yvonne LU ; Sundquist, Kristina LU and Jönsson, Tommy LU
- organization
-
- Family Medicine and Clinical Epidemiology (research group)
- Medicine/Emergency Medicine, Lund
- Diabetes (research group)
- EXODIAB: Excellence of Diabetes Research in Sweden
- Division of Food and Pharma
- EpiHealth: Epidemiology for Health
- Family medicine, cardiovascular medicine and genetics (research group)
- publishing date
- 2024-10
- type
- Contribution to journal
- publication status
- published
- subject
- in
- American Journal of Human Biology
- volume
- 36
- issue
- 10
- article number
- e24134
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:38989782
- scopus:85198119334
- ISSN
- 1042-0533
- DOI
- 10.1002/ajhb.24134
- language
- English
- LU publication?
- yes
- id
- 53956b96-5de0-4be1-be7a-1175c8b8acb7
- date added to LUP
- 2024-11-28 14:01:47
- date last changed
- 2025-07-11 08:52:46
@article{53956b96-5de0-4be1-be7a-1175c8b8acb7, abstract = {{<p>Objectives: Experimental and small human studies have indicated that high total adiponectin levels have beneficial cardiometabolic effects. In contrast, however, high total adiponectin levels are also associated with higher all-cause and cardiovascular mortality in thoroughly adjusted epidemiological studies. To gain further insight into these seemingly contradictory results, we report results on total adiponectin from the indigenous Melanesian population of Kitava, Trobriand Islands, Papua New Guinea, where an apparent absence of cardiometabolic disease has been previously reported. Methods: Fasting levels of serum total adiponectin were measured cross-sectionally in ≥40-year-old Kitavans (n = 102) and Swedish controls matched for age and sex (n = 108). Multivariable linear regression was used for the analysis of associations with total adiponectin when controlled for group, sex, smoking, hypertension and/or type 2 diabetes, age, and body mass index. Results: Total adiponectin was lower for Kitavans compared to Swedish controls (Median [Mdn] 4.6 μg/mL, range 1.0–206 μg/mL and Mdn 9.7 μg/mL, range 3.1–104 μg/mL, respectively, r =.64, p <.001). Lower total adiponectin was associated with Kitavan group, male sex (only in Swedish controls), smoking (only in Kitavans and Swedish controls combined), younger age (not in Swedish controls), higher BMI, lower total, low-density lipoprotein, high-density lipoprotein (HDL) (only in Kitavans and Swedish controls combined), and non-HDL cholesterol, and higher anti-PC IgG (only in Kitavans and Swedish controls combined). Conclusion: Total adiponectin in Kitavans was significantly lower than in Swedish controls.</p>}}, author = {{Carrera-Bastos, Pedro and Fontes-Villalba, Maelán and Ahrén, Bo and Lindblad, Ulf and Råstam, Lennart and Frostegård, Johan and Åkerfeldt, Torbjörn and Granfeldt, Yvonne and Sundquist, Kristina and Jönsson, Tommy}}, issn = {{1042-0533}}, language = {{eng}}, number = {{10}}, publisher = {{Wiley-Blackwell}}, series = {{American Journal of Human Biology}}, title = {{Total adiponectin in indigenous Melanesians on Kitava}}, url = {{http://dx.doi.org/10.1002/ajhb.24134}}, doi = {{10.1002/ajhb.24134}}, volume = {{36}}, year = {{2024}}, }